CD147 inhibitors as a treatment for melanoma: Promising agents against SARS-CoV-2 infection

Dermatol Ther. 2020 Nov;33(6):e14449. doi: 10.1111/dth.14449. Epub 2020 Nov 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • Basigin / antagonists & inhibitors*
  • Basigin / metabolism
  • COVID-19 / drug therapy*
  • COVID-19 / immunology
  • COVID-19 / metabolism
  • COVID-19 / virology
  • Host-Pathogen Interactions
  • Humans
  • Melanoma / drug therapy*
  • Melanoma / immunology
  • SARS-CoV-2 / drug effects*
  • SARS-CoV-2 / immunology
  • SARS-CoV-2 / pathogenicity
  • Signal Transduction
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / immunology
  • Skin Neoplasms / metabolism

Substances

  • Antineoplastic Agents
  • Antiviral Agents
  • BSG protein, human
  • Basigin

Supplementary concepts

  • COVID-19 drug treatment